123 related articles for article (PubMed ID: 7696440)
1. Acute intermittent porphyria: diagnostic conundrums.
Wassif WS; Deacon AC; Floderus Y; Thunell S; Peters TJ
Eur J Clin Chem Clin Biochem; 1994 Dec; 32(12):915-21. PubMed ID: 7696440
[TBL] [Abstract][Full Text] [Related]
2. Acute intermittent porphyria--impact of mutations found in the hydroxymethylbilane synthase gene on biochemical and enzymatic protein properties.
Ulbrichova D; Hrdinka M; Saudek V; Martasek P
FEBS J; 2009 Apr; 276(7):2106-15. PubMed ID: 19292878
[TBL] [Abstract][Full Text] [Related]
3. Validation and evaluation of two porphobilinogen deaminase activity assays for diagnosis of acute intermittent porphyria.
Lin CN; Huang YC; Ro LS; Liao MF; Ning HC; Kuo HC
Clin Chim Acta; 2018 Apr; 479():1-6. PubMed ID: 29317194
[TBL] [Abstract][Full Text] [Related]
4. Porphobilinogen deaminase gene mutations in Polish patients with non-erythroid acute intermittent porphyria.
Szlendak U; Lipniacka A; Bianketti J; Podolak-Dawidziak M; Bykowska K
Adv Clin Exp Med; 2015; 24(1):63-8. PubMed ID: 25923088
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of hydroxymethylbilane synthase mutations causing acute intermittent porphyria: evidence for an ancestral founder of the common G111R mutation.
De Siervi A; Rossetti MV; Parera VE; Astrin KH; Aizencang GI; Glass IA; Batlle AM; Desnick RJ
Am J Med Genet; 1999 Oct; 86(4):366-75. PubMed ID: 10494093
[TBL] [Abstract][Full Text] [Related]
6. Acute intermittent porphyria and mental illness--a family study.
Patience DA; Blackwood DH; McColl KE; Moore MR
Acta Psychiatr Scand; 1994 Apr; 89(4):262-7. PubMed ID: 8023693
[TBL] [Abstract][Full Text] [Related]
7. Safety, pharmacokinetics and pharmocodynamics of recombinant human porphobilinogen deaminase in healthy subjects and asymptomatic carriers of the acute intermittent porphyria gene who have increased porphyrin precursor excretion.
Sardh E; Rejkjaer L; Andersson DE; Harper P
Clin Pharmacokinet; 2007; 46(4):335-49. PubMed ID: 17375984
[TBL] [Abstract][Full Text] [Related]
8. [Acute intermittent porphyria and chronic transaminase elevation].
Raigal Martín MY; Lledó Navarro JL; Raigal Martín JM; Muriel Patino E; Pérez Pérez E; Moreno Prat M
Gastroenterol Hepatol; 2008 Apr; 31(4):225-8. PubMed ID: 18405488
[TBL] [Abstract][Full Text] [Related]
9. Acute intermittent porphyria: the in vitro expression of mutant hydroxymethylbilane synthase.
Ong PM; Lanyon WG; Graham G; Hift RJ; Halkett J; Moore MR; Connor JM
Mol Cell Probes; 1997 Aug; 11(4):293-6. PubMed ID: 9281416
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of acute intermittent porphyria: a subtype with normal erythrocyte porphobilinogen deaminase activity in Germany.
Gross U; Honcamp M; Doss MO
Eur J Clin Chem Clin Biochem; 1996 Aug; 34(8):613-8. PubMed ID: 8877336
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of a common hotspot variant in acute intermittent porphyria sheds light on the mechanism of hydroxymethylbilane synthase function.
Christie MS; Laitaoja M; Aarsand AK; Kallio JP; Bustad HJ
FEBS Open Bio; 2022 Dec; 12(12):2136-2146. PubMed ID: 36115019
[TBL] [Abstract][Full Text] [Related]
12. Identification of two novel mutations in the hydroxymethylbilane synthase gene in three patients from two unrelated families with acute intermittent porphyria.
Ong PM; Lanyon WG; Hift RJ; Halkett J; Cramp CE; Moore MR; Connor JM
Hum Hered; 1998; 48(1):24-9. PubMed ID: 9463797
[TBL] [Abstract][Full Text] [Related]
13. HMBS gene mutations and hydroxymethylbilane synthase activity in acute intermittent porphyria: A systematic review.
Li S; Lei JJ; Dong BX; Ren Y; Yang J
Medicine (Baltimore); 2023 Sep; 102(39):e35144. PubMed ID: 37773850
[TBL] [Abstract][Full Text] [Related]
14. R173W mutation of hydroxymethylbilane synthetase is associated with acute intermittent porphyria complicated with rhabdomyolysis: the first report.
Chen MC; Chang CJ; Lu YH; Niu DM; Lou HY; Chang CC
J Clin Gastroenterol; 2015 Mar; 49(3):256-7. PubMed ID: 25389600
[No Abstract] [Full Text] [Related]
15. Acute intermittent porphyria: novel missense mutations in the human hydroxymethylbilane synthase gene.
Ramdall RB; Cunha L; Astrin KH; Katz DR; Anderson KE; Glucksman M; Bottomley SS; Desnick RJ
Genet Med; 2000; 2(5):290-5. PubMed ID: 11399210
[TBL] [Abstract][Full Text] [Related]
16. Acute intermittent porphyria: laboratory diagnosis by molecular methods.
Schreiber WE
Clin Lab Med; 1995 Dec; 15(4):943-56. PubMed ID: 8838232
[TBL] [Abstract][Full Text] [Related]
17. Circulating fluorocytes at the first attack of acute intermittent porphyria: a missing link in the pathogenesis.
Lam CW; Lau KC; Mak CM; Tsang MW; Chan YW
Clin Chim Acta; 2011 Jan; 412(1-2):208-12. PubMed ID: 20850424
[TBL] [Abstract][Full Text] [Related]
18. New mutations of the hydroxymethylbilane synthase gene in German patients with acute intermittent porphyria.
Gross U; Puy H; Doss M; Robreau AM; Nordmann Y; Doss MO; Deybach JC
Mol Cell Probes; 1999 Dec; 13(6):443-7. PubMed ID: 10657149
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of latent acute intermittent porphyria by genetic analysis.
De Siervi A; Varela LS; Parera VE; Batlle AM; Rossetti MV
Ann Clin Biochem; 2001 Mar; 38(Pt 2):149-52. PubMed ID: 11269757
[No Abstract] [Full Text] [Related]
20. Acute intermittent porphyria: heterogeneity of mutations in the hydroxymethylbilane synthase gene in Italy.
Martinez di Montemuros F; Di Pierro E; Biolcati G; Rocchi E; Bissolotti E; Tavazzi D; Fiorelli G; Cappellini MD
Blood Cells Mol Dis; 2001; 27(6):961-70. PubMed ID: 11831862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
